This is a Validated Antibody Database (VAD) review about human CD62L, based on 122 published articles (read how Labome selects the articles), using CD62L antibody in all methods. It is aimed to help Labome visitors find the most suited CD62L antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD62L synonym: CD62L; LAM1; LECAM1; LEU8; LNHR; LSEL; LYAM1; PLNHR; TQ1

others
  • flow cytometry; human; loading ...; fig 3a
 CD62L antibody (Biolegend, DREG-56) was used in flow cytometry on human samples (fig 3a). Cell Stem Cell (2019) ncbi
 CD62L antibody (BioLegend, DREG-56) was used . J Clin Invest (2018) ncbi
 CD62L antibody (BioLegend, 304812) was used . J Cell Sci (2018) ncbi
Invitrogen
mouse monoclonal (DREG56)
  • flow cytometry; human; loading ...; fig 3c
In order to evaluate the effectiveness of adoptive natural killer cell therapy against the pulmonary metastasis of Ewing sarcoma, Invitrogen CD62L antibody (eBiosciences, DREG-56) was used in flow cytometry on human samples (fig 3c). Oncoimmunology (2017) ncbi
mouse monoclonal (DREG56)
  • western blot; human; loading ...; fig 3d
In order to report the effects of long-term lipopolysaccharide exposure on monocytes, Invitrogen CD62L antibody (Thermo Fischer Scientific, MA1-10259) was used in western blot on human samples (fig 3d). Toxicol In Vitro (2017) ncbi
mouse monoclonal (DREG-56 (DREG56))
  • flow cytometry; human; loading ...; fig s1
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Invitrogen CD62L antibody (Thermo Fisher Scientific, 17-0629) was used in flow cytometry on human samples (fig s1). Cell Res (2017) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; loading ...; fig s2
Invitrogen CD62L antibody (eBioscience, DREG-56) was used in flow cytometry on human samples (fig s2). Oncoimmunology (2017) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig s2
Invitrogen CD62L antibody (eBioscience, DREG-56) was used in flow cytometry on human samples (fig s2). Oncoimmunology (2017) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; loading ...
In order to characterize gammadelta T cell subsets from healthy humans, Invitrogen CD62L antibody (ebioscience, DREG-56) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; loading ...; fig s5c
Invitrogen CD62L antibody (eBiosciences, DREG-56) was used in flow cytometry on human samples (fig s5c). PLoS Pathog (2016) ncbi
mouse monoclonal (DREG-56 (DREG56))
  • flow cytometry; human; loading ...; fig 2c
In order to propose that female sex protects against systemic inflammation-induced endothelial dysfunction, Invitrogen CD62L antibody (eBioscience, 47-0629-42) was used in flow cytometry on human samples (fig 2c). J Clin Invest (2017) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; loading ...
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, Invitrogen CD62L antibody (Invitrogen, Dreg 56) was used in flow cytometry on human samples . Clin Immunol (2016) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; fig 1h
In order to characterize side population T cells, Invitrogen CD62L antibody (eBiosciences, DREG-56) was used in flow cytometry on human samples (fig 1h). J Clin Invest (2016) ncbi
mouse monoclonal (DREG-56 (DREG56))
  • flow cytometry; human; loading ...; fig 5a
Invitrogen CD62L antibody (eBiosciences, 48-0629) was used in flow cytometry on human samples (fig 5a). Eur J Immunol (2016) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; loading ...; fig s1
In order to characterize the immune responses of children immunized with Plasmodium falciparum apical membrane antigen 1, Invitrogen CD62L antibody (eBioscience, Dreg-56) was used in flow cytometry on human samples (fig s1). Vaccine (2016) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; loading ...; fig 1c
In order to develop a robust in vitro model to study chronic lymphocytic leukemia B cell receptor ligation, Invitrogen CD62L antibody (eBioscience, DREG-56) was used in flow cytometry on human samples (fig 1c). Br J Cancer (2016) ncbi
mouse monoclonal (DREG-56 (DREG56))
  • flow cytometry; human; fig 5
Invitrogen CD62L antibody (eBioscience, DREG-56) was used in flow cytometry on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; fig 2
In order to analyze the difference in immune profiles at the pandemic epicenter in two pandemic Influenza A (H1N1) pdm09 virus waves, Invitrogen CD62L antibody (Invitrogen, Dreg-56) was used in flow cytometry on human samples (fig 2). Arch Med Res (2015) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; loading ...; fig e4a
In order to discuss the importance of IL-5 positive Th2 cells to allergies, Invitrogen CD62L antibody (eBioscience, DREG-56) was used in flow cytometry on human samples (fig e4a). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; fig 2.b,c
In order to study the role of CREB coactivator CRTC2 in hepatic lipid metabolism, Invitrogen CD62L antibody (eBioscience, MHCD62L04) was used in flow cytometry on human samples (fig 2.b,c). Nature (2015) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; fig 2.b,c
In order to evaluate the immune efficacy of a single-dose inactivated hepatitis A vaccination, Invitrogen CD62L antibody (eBioscience, MHCD62L04) was used in flow cytometry on human samples (fig 2.b,c). Vaccine (2015) ncbi
mouse monoclonal (DREG-56 (DREG56))
  • immunohistochemistry; human; 1:100
  • western blot; human; 1:500
In order to study dysregulation of CD62L expression during HIV infection, Invitrogen CD62L antibody (eBioscience, DEG56) was used in immunohistochemistry on human samples at 1:100 and in western blot on human samples at 1:500. J Virol (2015) ncbi
mouse monoclonal (DREG56)
  • immunohistochemistry; human; 1:100
  • western blot; human; 1:500
In order to study dysregulation of CD62L expression during HIV infection, Invitrogen CD62L antibody (eBioscience, DEG56) was used in immunohistochemistry on human samples at 1:100 and in western blot on human samples at 1:500. J Virol (2015) ncbi
mouse monoclonal (LT-TD180)
  • flow cytometry; human
In order to study dysregulation of CD62L expression during HIV infection, Invitrogen CD62L antibody (Thermo, LT-TD180) was used in flow cytometry on human samples . J Virol (2015) ncbi
mouse monoclonal (DREG-56 (DREG56))
  • flow cytometry; human; fig s3
Invitrogen CD62L antibody (eBioscience, DREG56) was used in flow cytometry on human samples (fig s3). Infect Immun (2015) ncbi
mouse monoclonal (DREG-56 (DREG56))
  • flow cytometry; human; fig s1
In order to describe the phenotype and functional potential of metastatic differentiated thyroid cancer-associated PD-1 positive T cells, Invitrogen CD62L antibody (eBioscience, DREG-56) was used in flow cytometry on human samples (fig s1). Cancer Immunol Res (2015) ncbi
mouse monoclonal (DREG-56 (DREG56))
  • flow cytometry; human; tbl 2
In order to test if flow cytometry can be used to find mantle cell lymphoma, Invitrogen CD62L antibody (eBioscience, DREG-56) was used in flow cytometry on human samples (tbl 2). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
In order to report the immune responses elicited in an outpatient Phase 2 clinical trial in which subjects were vaccinated with CVD 1208S (DeltaguaBA, Deltaset, Deltasen S. flexneri 2a), Invitrogen CD62L antibody (Caltag, Dreg-56) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human
In order to developed a strategy to expand umbilical cord blood T cells and test their effects after transplantation, Invitrogen CD62L antibody (Invitrogen, Dreg-56) was used in flow cytometry on human samples . Leukemia (2015) ncbi
mouse monoclonal (DREG-56 (DREG56))
  • flow cytometry; human; fig s1
Invitrogen CD62L antibody (eBioscience, DREG56) was used in flow cytometry on human samples (fig s1). PLoS Pathog (2011) ncbi
mouse monoclonal (DREG-56 (DREG56))
  • flow cytometry; mouse; fig 3
In order to compare the therapeutic efficacy of CD19-specific human primary T cells that constitutively express gamma(c)-cytokines, Invitrogen CD62L antibody (eBioscience, DREG-56) was used in flow cytometry on mouse samples (fig 3). Blood (2010) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; fig 1
In order to investigate how anti-CD3 monoclonal antibodies alter human immune responses in type 1 diabetes, Invitrogen CD62L antibody (Caltag, Dreg-56) was used in flow cytometry on human samples (fig 1). Clin Immunol (2010) ncbi
mouse monoclonal (DREG56)
  • immunohistochemistry - frozen section; human; fig 2
In order to propose an autocrine role for the cytotrophoblast L-selectin adhesion system in forming and maintaining cell columns during the early stages of placental development, Invitrogen CD62L antibody (Caltag, DREG-56) was used in immunohistochemistry - frozen section on human samples (fig 2). Dev Biol (2006) ncbi
mouse monoclonal (DREG56)
  • immunohistochemistry - paraffin section; human; fig 1
In order to elucidate how nicotine impairs the development of cell columns, Invitrogen CD62L antibody (Caltag, DREG-56) was used in immunohistochemistry - paraffin section on human samples (fig 1). Reprod Toxicol (2006) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; tbl 2
In order to use flow cytometry to study granzyme A, B, and K expression in human peripheral blood lymphocytes, Invitrogen CD62L antibody (Caltag, DREG-56) was used in flow cytometry on human samples (tbl 2). Eur J Immunol (2005) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; tbl 2
In order to use flow cytometry to study granzyme A, B, and K expression in human peripheral blood lymphocytes, Invitrogen CD62L antibody (Caltag, DREG-56) was used in flow cytometry on human samples (tbl 2). Eur J Immunol (2005) ncbi
mouse monoclonal (DREG-56 (DREG56))
  • flow cytometry; human
Invitrogen CD62L antibody (eBioscience, DREG-56) was used in flow cytometry on human samples . Blood (2005) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
In order to show that T cell expansion and contractions in persistent viral infections is not limited to the acute phase of infection, but continues in latent infection, Invitrogen CD62L antibody (Caltag, DREG-56) was used in flow cytometry on human samples . Eur J Immunol (2005) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human
In order to show that T cell expansion and contractions in persistent viral infections is not limited to the acute phase of infection, but continues in latent infection, Invitrogen CD62L antibody (Caltag, DREG-56) was used in flow cytometry on human samples . Eur J Immunol (2005) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; fig 3
In order to report that leukocyte adhesion is involved in the vascular homing of endothelial progenitor cells, Invitrogen CD62L antibody (Caltag, DREG-56) was used in flow cytometry on human samples (fig 3). J Immunol (2004) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; tbl 1
In order to compare human saphenous vein endothelial cells with human umbilical vein endothelial cells, Invitrogen CD62L antibody (Caltag, DREG-56) was used in flow cytometry on human samples (tbl 1). Atherosclerosis (2004) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; fig 7c
In order to study interactions among endothelial cells, blood, and biomaterials, Invitrogen CD62L antibody (Caltag, DREG-56) was used in flow cytometry on human samples (fig 7c). J Biomed Mater Res A (2003) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; fig 7c
In order to study interactions among endothelial cells, blood, and biomaterials, Invitrogen CD62L antibody (Caltag, DREG-56) was used in flow cytometry on human samples (fig 7c). J Biomed Mater Res A (2003) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human
In order to test if CD103 has a regulatory role in the microenvironment of the epithelial cell layer, Invitrogen CD62L antibody (Caltag, DREG-56) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
In order to test if CD103 has a regulatory role in the microenvironment of the epithelial cell layer, Invitrogen CD62L antibody (Caltag, DREG-56) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human
In order to characterize CD34+ umbilical cord blood cells, Invitrogen CD62L antibody (Caltag, DREG-56) was used in flow cytometry on human samples . J Hematother Stem Cell Res (2003) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
In order to characterize CD34+ umbilical cord blood cells, Invitrogen CD62L antibody (Caltag, DREG-56) was used in flow cytometry on human samples . J Hematother Stem Cell Res (2003) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human
In order to report that Varicella-zoster virus infects human tonsillar CD4(+) T cells, Invitrogen CD62L antibody (Caltag, DREG-56) was used in flow cytometry on human samples . J Virol (2002) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; fig 2
In order to measure interleukin-10 and transforming growth factor-beta1 produced by T cells from healthy volunteer donors treated with recombinant human G-CSF, Invitrogen CD62L antibody (Caltag Laboratories, clone DREG-56) was used in flow cytometry on human samples (fig 2). Blood (2002) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; fig 2
In order to characterize the localization and function of STRL33/Bonzo, Invitrogen CD62L antibody (Caltag, DREG-56) was used in flow cytometry on human samples (fig 2). Blood (2000) ncbi
mouse monoclonal (DREG56)
  • blocking or activating experiments; human
In order to identify adhesion molecules and study mechanisms that regulate hematopoietic stem and progenitor cell homing to the bone marrow, Invitrogen CD62L antibody (Caltag, DREG-56) was used in blocking or activating experiments on human samples . Blood (2000) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human
In order to determine the number of CD4, CCR5, and CXCR4 antibody-binding sites on various T cells and macrophages, Invitrogen CD62L antibody (Caltag, DREG-56) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (1999) ncbi
BioLegend
mouse monoclonal (DREG-56)
  • mass cytometry; human; loading ...; fig 2d
BioLegend CD62L antibody (Biolegend, 304835) was used in mass cytometry on human samples (fig 2d). Biomark Res (2022) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig s4e
BioLegend CD62L antibody (Biolenged, 304835) was used in flow cytometry on human samples (fig s4e). Science (2021) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD62L antibody (Biolegend, DREG-56) was used in flow cytometry on human samples (fig 1c). EMBO Mol Med (2021) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig s7b
BioLegend CD62L antibody (Biolegend, 304822) was used in flow cytometry on human samples (fig s7b). Nat Commun (2019) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD62L antibody (Biolegend, DREG-56) was used in flow cytometry on human samples (fig 3a). Cell Stem Cell (2019) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig s2b
BioLegend CD62L antibody (Biolegend, 304833) was used in flow cytometry on human samples (fig s2b). Cell (2019) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig s3
BioLegend CD62L antibody (Biolegend, 304805) was used in flow cytometry on human samples (fig s3). Leukemia (2019) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD62L antibody (BioLegend, 304822) was used in flow cytometry on human samples (fig 2a). Cell Rep (2018) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD62L antibody (BioLegend, DREG-56) was used in flow cytometry on human samples (fig s1). J Clin Invest (2018) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; fig 7
In order to study the involvement of Notch signaling in NK cell lineage determination, BioLegend CD62L antibody (biolegend, DREG-56) was used in flow cytometry on human samples (fig 7). J Immunol (2017) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 2
BioLegend CD62L antibody (BioLegend, 304,821) was used in flow cytometry on human samples (fig 2). Immun Ageing (2017) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 1a
In order to study the expression of CCR10 and CXCR3 in circulating CD8 T cells specific for human herpes simplex virus, BioLegend CD62L antibody (BioLegend, DREG-56) was used in flow cytometry on human samples (fig 1a). J Virol (2017) ncbi
mouse monoclonal (DREG-56)
  • mass cytometry; human; loading ...; fig s3a
In order to map the lineage of human dendritic cells, BioLegend CD62L antibody (BioLegend, DREG-56) was used in mass cytometry on human samples (fig s3a). Science (2017) ncbi
mouse monoclonal (DREG-56)
  • mass cytometry; human; fig s8
BioLegend CD62L antibody (BioLegend, 304802) was used in mass cytometry on human samples (fig s8). Nature (2017) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 2f
In order to observe that the use of chimeric antigen receptor technology is a clinically applicable refinement of regulatory T cell therapy for organ transplantation, BioLegend CD62L antibody (BioLegend, DREG-56) was used in flow cytometry on human samples (fig 2f). Am J Transplant (2017) ncbi
mouse monoclonal (DREG-56)
  • immunocytochemistry; human; loading ...; fig s3c
BioLegend CD62L antibody (BioLegend, DREG-56) was used in immunocytochemistry on human samples (fig s3c). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 3e
BioLegend CD62L antibody (BioLegend, DREG-56) was used in flow cytometry on human samples (fig 3e). Sci Rep (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD62L antibody (Biolegend, DREG-56) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; tbl 1
BioLegend CD62L antibody (BioLegend, DREG-56) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig s9
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend CD62L antibody (BioLegend, DREG-56) was used in flow cytometry on human samples (fig s9). Am J Transplant (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; fig s7
BioLegend CD62L antibody (BioLegend, 304813) was used in flow cytometry on human samples (fig s7). Nat Biotechnol (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 4a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CD62L antibody (biolegend, DREG-56) was used in flow cytometry on human samples (fig 4a). J Immunol (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; fig 1
BioLegend CD62L antibody (Biolegend, DREG-56) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig s1a
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend CD62L antibody (Biolegend, DREG-56) was used in flow cytometry on human samples (fig s1a). J Immunol (2015) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...
In order to examine the effects of immunosuppressive agents on Polyomavirus BKV-specific T cells, BioLegend CD62L antibody (Biolegend, DREG-56) was used in flow cytometry on human samples . Kidney Int (2015) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; fig 4
In order to determine the differential regulation of the inflammatory phenotype of brain microvascular endothelial cells by pro-inflammatory TNFalpha and IL-1beta, BioLegend CD62L antibody (Biolegend, 304809) was used in flow cytometry on human samples (fig 4). J Neuroinflammation (2015) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
BioLegend CD62L antibody (Biolegend, 304810) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
BioLegend CD62L antibody (Biolegend, DREG-56) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (DREG-56)
BioLegend CD62L antibody (Biolegend, 304822) was used . Cancer Res (2015) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 2f
In order to discuss the therapeutic use of ex vivo-generated Akt-inhibited minor histocompatibility antigen-specific CD8+ T cells, BioLegend CD62L antibody (BioLegend, DREG56) was used in flow cytometry on human samples (fig 2f). Blood (2014) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
BioLegend CD62L antibody (Biolegend, Dreg56) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
BioLegend CD62L antibody (Biolegend, DREG-56) was used in flow cytometry on human samples . Med Microbiol Immunol (2014) ncbi
mouse monoclonal (DREG-56)
BioLegend CD62L antibody (Biolegend, 304822) was used . PLoS ONE (2014) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; 1 ug/ml
BioLegend CD62L antibody (BioLegend, DREG-56) was used in flow cytometry on human samples at 1 ug/ml. Sci Rep (2014) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend CD62L antibody (Biolegend, DREG-56) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
BioLegend CD62L antibody (Biolegend, DREG-56) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (B-8)
  • flow cytometry; human; fig 3d
Santa Cruz Biotechnology CD62L antibody (Santa Cruz Biotechnology, sc-390756) was used in flow cytometry on human samples (fig 3d). Diabetes (2020) ncbi
mouse monoclonal (LAM1-116)
  • immunohistochemistry; human; 1:250
In order to study dysregulation of CD62L expression during HIV infection, Santa Cruz Biotechnology CD62L antibody (Santa, Lam1-116) was used in immunohistochemistry on human samples at 1:250. J Virol (2015) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; fig 1
Santa Cruz Biotechnology CD62L antibody (Santa Cruz Biotechnology, sc-18851) was used in flow cytometry on human samples (fig 1). J Immunol (2014) ncbi
Beckman Coulter
mouse monoclonal (DREG56)
  • flow cytometry; human; loading ...
Beckman Coulter CD62L antibody (Beckman Coulter, IM2713U) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; fig 1a
Beckman Coulter CD62L antibody (Beckman Coulter, DREG56) was used in flow cytometry on human samples (fig 1a). Int J Cancer (2017) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, Beckman Coulter CD62L antibody (Beckman Coulter (Immunotech), Dreg 56) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (DREG56)
  • flow cytometry; human; loading ...; fig 1
In order to report the exercise-induced changes on the blood cell composition of patients with metabolic syndrome, Beckman Coulter CD62L antibody (IOTest, IM1231U) was used in flow cytometry on human samples (fig 1). Cytometry B Clin Cytom (2018) ncbi
EuroBioSciences
mouse monoclonal (LT-TD180)
  • flow cytometry; human; loading ...; fig 4b
EuroBioSciences CD62L antibody (EuroBiosciences, LT-TD180) was used in flow cytometry on human samples (fig 4b). J Clin Invest (2017) ncbi
BD Biosciences
mouse monoclonal (DREG-56)
  • flow cytometry; human; fig 3f
BD Biosciences CD62L antibody (BD Bioscience, DREG-56) was used in flow cytometry on human samples (fig 3f). J Immunother Cancer (2021) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; mouse; 1:1000; loading ...
BD Biosciences CD62L antibody (BD Biosciences, 559772) was used in flow cytometry on mouse samples at 1:1000. Cell Rep Med (2021) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD62L antibody (BD, 555543) was used in flow cytometry on human samples (fig 3a). Signal Transduct Target Ther (2021) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD62L antibody (BD, DREG-56) was used in flow cytometry on human samples (fig 1c). EMBO Mol Med (2021) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; fig 1c
BD Biosciences CD62L antibody (BD, DREG-56) was used in flow cytometry on human samples (fig 1c). Nature (2019) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; 1:12.5; loading ...; fig 6c
BD Biosciences CD62L antibody (BD Biosciences, 561916) was used in flow cytometry on human samples at 1:12.5 (fig 6c). Nat Commun (2019) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD62L antibody (BD Biosciences, 555544) was used in flow cytometry on human samples (fig 5a). BMC Immunol (2019) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig s5a
BD Biosciences CD62L antibody (BD Biosciences, DREG-56) was used in flow cytometry on human samples (fig s5a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (SK11)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD62L antibody (BD Biosciences, SK11) was used in flow cytometry on human samples (fig 2a). J Clin Invest (2018) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD62L antibody (BD Biosciences, DREG-56) was used in flow cytometry on human samples (fig 2a). Nat Med (2018) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD62L antibody (BD Biosciences, 555543) was used in flow cytometry on human samples (fig 3a). Oncotarget (2018) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BD Biosciences CD62L antibody (BD, DREG-56) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 3d
BD Biosciences CD62L antibody (BD, 555543) was used in flow cytometry on human samples (fig 3d). Cell (2017) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig s1g
In order to use CD49a expression to define subsets of tissue-resident memory T cells in the skin, BD Biosciences CD62L antibody (BD Bioscience, Dreg-56) was used in flow cytometry on human samples (fig s1g). Immunity (2017) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CD62L antibody (BD, DREG-56) was used in flow cytometry on human samples (fig 4a). PLoS ONE (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; tbl 3
BD Biosciences CD62L antibody (BD Pharmingen, DREG-56) was used in flow cytometry on human samples (tbl 3). Brain Behav (2016) ncbi
mouse monoclonal (SK11)
  • flow cytometry; human; loading ...; fig 3c
BD Biosciences CD62L antibody (BD Biosciences, SK11) was used in flow cytometry on human samples (fig 3c). Oncotarget (2016) ncbi
mouse monoclonal (SK11)
  • flow cytometry; human; fig s3
In order to identify and characterize CXCR5hiCD44hiCD8 T cells in HIV-infected individuals, BD Biosciences CD62L antibody (BD, 341012) was used in flow cytometry on human samples (fig s3). PLoS Pathog (2016) ncbi
mouse monoclonal (SK11)
  • flow cytometry; human; loading ...; fig st9
In order to characterize American patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, BD Biosciences CD62L antibody (BD Biosciences, SK11) was used in flow cytometry on human samples (fig st9). JCI Insight (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig s2e
BD Biosciences CD62L antibody (BD, DREG-56) was used in flow cytometry on human samples (fig s2e). J Clin Invest (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; mouse; loading ...; fig st1
BD Biosciences CD62L antibody (BD Pharmingen, DREG-56) was used in flow cytometry on mouse samples (fig st1). J Clin Invest (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 5c
BD Biosciences CD62L antibody (BD Biosciences, DREG-56) was used in flow cytometry on human samples (fig 5c). J Immunol (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...
In order to assess the ability of human cystatin C to alter pathogenic activated monocytes and modulate Crohn's disease, BD Biosciences CD62L antibody (BD Pharmingen, DREG-56) was used in flow cytometry on human samples . J Leukoc Biol (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; 1:100; loading ...; fig s6b
BD Biosciences CD62L antibody (BD Biosciences, DREG56) was used in flow cytometry on human samples at 1:100 (fig s6b). Nat Commun (2016) ncbi
mouse monoclonal (DREG-56)
  • other; human; 500 ug/ml; fig 2
BD Biosciences CD62L antibody (Becton Dickinson, 555542) was used in other on human samples at 500 ug/ml (fig 2). J Extracell Vesicles (2016) ncbi
mouse monoclonal (SK11)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD62L antibody (BD, 341012) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; fig 1
BD Biosciences CD62L antibody (BD Biosciences, DREG-56) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD62L antibody (BD Pharmingen, Dreg56) was used in flow cytometry on human samples (fig 5a). PLoS ONE (2016) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; fig 1
In order to elucidate mechanisms that regulate T cell glycolytic metabolism, BD Biosciences CD62L antibody (BD Bioscience, DREG56) was used in flow cytometry on human samples (fig 1). Nat Immunol (2016) ncbi
mouse monoclonal (SK11)
  • flow cytometry; rhesus macaque; fig 4
In order to elucidate how CD8 positive T cells suppress virus replication during simian immunodeficiency virus infection, BD Biosciences CD62L antibody (BD Biosciences, Sk11) was used in flow cytometry on rhesus macaque samples (fig 4). J Virol (2015) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, BD Biosciences CD62L antibody (BD Biosciences, clone DREG-56) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; fig s1
BD Biosciences CD62L antibody (BD Biosciences, DREG-56) was used in flow cytometry on human samples (fig s1). PLoS ONE (2015) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human; fig 2
BD Biosciences CD62L antibody (BD Biosciences, DREG-56) was used in flow cytometry on human samples (fig 2). J Autoimmun (2015) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
BD Biosciences CD62L antibody (BD Biosciences, Dreg56) was used in flow cytometry on human samples . Cytotherapy (2015) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
In order to study the effect of mesenchymal stem cells on the anti-bacterial activity of neutrophil granulocytes, BD Biosciences CD62L antibody (BD Bioscience, DREG-56) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
In order to report the immune responses elicited in an outpatient Phase 2 clinical trial in which subjects were vaccinated with CVD 1208S (DeltaguaBA, Deltaset, Deltasen S. flexneri 2a), BD Biosciences CD62L antibody (Becton-Dickinson, Dreg-56) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
In order to examine the effect of lytic EBV antigen-specific CD8+ T cells on EBV infection in humanized mice, BD Biosciences CD62L antibody (BD Pharmigen, DREG56) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
BD Biosciences CD62L antibody (BD Biosciences, DREG-56) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (DREG-56)
  • flow cytometry; human
BD Biosciences CD62L antibody (BD Biosciences, DREG-56) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
Articles Reviewed
  1. Jiang Z, Qin L, Tang Y, Liao R, Shi J, He B, et al. Human induced-T-to-natural killer cells have potent anti-tumour activities. Biomark Res. 2022;10:13 pubmed publisher
  2. Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, et al. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. J Immunother Cancer. 2021;9: pubmed publisher
  3. Li N, Torres M, Spetz M, Wang R, Peng L, Tian M, et al. CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice. Cell Rep Med. 2021;2:100297 pubmed publisher
  4. Weber E, Parker K, Sotillo E, Lynn R, Anbunathan H, Lattin J, et al. Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. Science. 2021;372: pubmed publisher
  5. Mo F, Duan S, Jiang X, Yang X, Hou X, Shi W, et al. Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy. Signal Transduct Target Ther. 2021;6:80 pubmed publisher
  6. Vavassori V, Mercuri E, Marcovecchio G, Castiello M, Schiroli G, Albano L, et al. Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. EMBO Mol Med. 2021;13:e13545 pubmed publisher
  7. Liu C, Teo M, Pek S, Wu X, Leong M, Tay H, et al. A Multifunctional Role of Leucine-Rich α-2-Glycoprotein 1 in Cutaneous Wound Healing Under Normal and Diabetic Conditions. Diabetes. 2020;69:2467-2480 pubmed publisher
  8. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed publisher
  9. Lynn R, Weber E, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293-300 pubmed publisher
  10. Götzke H, Kilisch M, Martínez Carranza M, Sograte Idrissi S, Rajavel A, Schlichthaerle T, et al. The ALFA-tag is a highly versatile tool for nanobody-based bioscience applications. Nat Commun. 2019;10:4403 pubmed publisher
  11. Zou F, Lu L, Liu J, Xia B, Zhang W, Hu Q, et al. Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56. Nat Commun. 2019;10:4109 pubmed publisher
  12. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed publisher
  13. Dagur R, Branch Woods A, Mathews S, Joshi P, Quadros R, Harms D, et al. Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infection. BMC Immunol. 2019;20:2 pubmed publisher
  14. Collins P, Cella M, Porter S, Li S, Gurewitz G, Hong H, et al. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells. Cell. 2019;176:348-360.e12 pubmed publisher
  15. Velázquez Avila M, Balandrán J, Ramírez Ramírez D, Velázquez Avila M, Sandoval A, Felipe López A, et al. High cortactin expression in B-cell acute lymphoblastic leukemia is associated with increased transendothelial migration and bone marrow relapse. Leukemia. 2019;33:1337-1348 pubmed publisher
  16. Kim C, Hu B, Jadhav R, Jin J, Zhang H, Cavanagh M, et al. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep. 2018;25:2148-2162.e5 pubmed publisher
  17. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  18. Boutboul D, Kuehn H, Van de Wyngaert Z, Niemela J, Callebaut I, Stoddard J, et al. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. J Clin Invest. 2018;128:3071-3087 pubmed publisher
  19. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y, Zheng Z, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724-730 pubmed publisher
  20. Risnes L, Christophersen A, Dahal Koirala S, Neumann R, Sandve G, Sarna V, et al. Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J Clin Invest. 2018;128:2642-2650 pubmed publisher
  21. Shi Y, Zhang P, Wang G, Liu X, Sun X, Zhang X, et al. Description of organ-specific phenotype, and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver. Oncotarget. 2018;9:15552-15565 pubmed publisher
  22. Buffone A, Anderson N, Hammer D. Migration against the direction of flow is LFA-1-dependent in human hematopoietic stem and progenitor cells. J Cell Sci. 2018;131: pubmed publisher
  23. Matos T, O Malley J, Lowry E, Hamm D, Kirsch I, Robins H, et al. Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing ?? T cell clones. J Clin Invest. 2017;127:4031-4041 pubmed publisher
  24. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed publisher
  25. Krogh Nielsen M, Hector S, Allen K, Subhi Y, Sørensen T. Altered activation state of circulating neutrophils in patients with neovascular age-related macular degeneration. Immun Ageing. 2017;14:18 pubmed publisher
  26. Hensel M, Peng T, Cheng A, De Rosa S, Wald A, Laing K, et al. Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells. J Virol. 2017;91: pubmed publisher
  27. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed publisher
  28. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  29. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  30. Mytych J, Romerowicz Misielak M, Koziorowski M. Long-term culture with lipopolysaccharide induces dose-dependent cytostatic and cytotoxic effects in THP-1 monocytes. Toxicol In Vitro. 2017;42:1-9 pubmed publisher
  31. Lu X, Horner J, Paul E, Shang X, Troncoso P, Deng P, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017;543:728-732 pubmed publisher
  32. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed publisher
  33. Millrud C, Kågedal A, Kumlien Georén S, Winqvist O, Uddman R, Razavi R, et al. NET-producing CD16high CD62Ldim neutrophils migrate to tumor sites and predict improved survival in patients with HNSCC. Int J Cancer. 2017;140:2557-2567 pubmed publisher
  34. Israel L, Wang Y, Bulek K, Della Mina E, Zhang Z, Pedergnana V, et al. Human Adaptive Immunity Rescues an Inborn Error of Innate Immunity. Cell. 2017;168:789-800.e10 pubmed publisher
  35. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed publisher
  36. Su S, Zou Z, Chen F, Ding N, Du J, Shao J, et al. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology. 2017;6:e1249558 pubmed publisher
  37. Boardman D, Philippeos C, Fruhwirth G, Ibrahim M, Hannen R, Cooper D, et al. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. Am J Transplant. 2017;17:931-943 pubmed publisher
  38. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  39. Ryan P, Sumaria N, Holland C, Bradford C, Izotova N, Grandjean C, et al. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc Natl Acad Sci U S A. 2016;113:14378-14383 pubmed
  40. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed publisher
  41. Faivre V, Lukaszewicz A, Payen D. Downregulation of Blood Monocyte HLA-DR in ICU Patients Is Also Present in Bone Marrow Cells. PLoS ONE. 2016;11:e0164489 pubmed publisher
  42. Rathod K, Kapil V, Velmurugan S, Khambata R, Siddique U, Khan S, et al. Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans. J Clin Invest. 2017;127:169-182 pubmed publisher
  43. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  44. Misra S, Selvam A, Wallenberg M, Ambati A, Matolcsy A, Magalhaes I, et al. Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells. Oncotarget. 2016;7:74686-74700 pubmed publisher
  45. Miles B, Miller S, Folkvord J, Levy D, Rakasz E, Skinner P, et al. Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV Infection. PLoS Pathog. 2016;12:e1005924 pubmed publisher
  46. Jung Y, Riven I, Feigelson S, Kartvelishvily E, Tohya K, Miyasaka M, et al. Three-dimensional localization of T-cell receptors in relation to microvilli using a combination of superresolution microscopies. Proc Natl Acad Sci U S A. 2016;113:E5916-E5924 pubmed
  47. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed publisher
  48. Boddupalli C, Nair S, Gray S, Nowyhed H, Verma R, Gibson J, et al. ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. J Clin Invest. 2016;126:3905-3916 pubmed publisher
  49. Fuchs S, Kaiser Labusch P, Bank J, Ammann S, Kolb Kokocinski A, Edelbusch C, et al. Tyrosine kinase 2 is not limiting human antiviral type III interferon responses. Eur J Immunol. 2016;46:2639-2649 pubmed publisher
  50. Ferre E, Rose S, Rosenzweig S, Burbelo P, Romito K, Niemela J, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1: pubmed
  51. Jiang J, Chen X, An H, Yang B, Zhang F, Cheng X. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep. 2016;6:32320 pubmed publisher
  52. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed publisher
  53. Xu Y, Chaudhury A, Zhang M, Savoldo B, Metelitsa L, Rodgers J, et al. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest. 2016;126:2678-88 pubmed publisher
  54. Wonner R, Wallner S, Orso E, Schmitz G. Effects of acute exercise on monocyte subpopulations in metabolic syndrome patients. Cytometry B Clin Cytom. 2018;94:596-605 pubmed publisher
  55. Ramos C, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, et al. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016;126:2588-96 pubmed publisher
  56. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed publisher
  57. Gren S, Janciauskiene S, Sandeep S, Jonigk D, Kvist P, Gerwien J, et al. The protease inhibitor cystatin C down-regulates the release of IL-? and TNF-? in lipopolysaccharide activated monocytes. J Leukoc Biol. 2016;100:811-822 pubmed
  58. Sommer A, Kordowski F, Büch J, Maretzky T, Evers A, Andrä J, et al. Phosphatidylserine exposure is required for ADAM17 sheddase function. Nat Commun. 2016;7:11523 pubmed publisher
  59. Graves S, Kouriba B, Diarra I, Daou M, Niangaly A, Coulibaly D, et al. Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate. Vaccine. 2016;34:2546-55 pubmed publisher
  60. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed publisher
  61. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  62. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  63. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  64. Simon S, Vignard V, Florenceau L, Dreno B, Khammari A, Lang F, et al. PD-1 expression conditions T cell avidity within an antigen-specific repertoire. Oncoimmunology. 2016;5:e1104448 pubmed
  65. Rombout A, Lust S, Offner F, Naessens E, Verhasselt B, Philippé J. Mimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation. Br J Cancer. 2016;114:704-12 pubmed publisher
  66. Liu L, Sommermeyer D, Cabanov A, Kosasih P, Hill T, Riddell S. Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy. Nat Biotechnol. 2016;34:430-4 pubmed publisher
  67. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  68. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed publisher
  69. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed publisher
  70. Arriaga Pizano L, Ferat Osorio E, Rodríguez Abrego G, Mancilla Herrera I, Domínguez Cerezo E, Valero Pacheco N, et al. Differential Immune Profiles in Two Pandemic Influenza A(H1N1)pdm09 Virus Waves at Pandemic Epicenter. Arch Med Res. 2015;46:651-8 pubmed publisher
  71. Whisenant T, Peralta E, Aarreberg L, Gao N, Head S, Ordoukhanian P, et al. The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells. PLoS ONE. 2015;10:e0144409 pubmed publisher
  72. Zhao E, Maj T, Kryczek I, Li W, Wu K, Zhao L, et al. Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nat Immunol. 2016;17:95-103 pubmed publisher
  73. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  74. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed publisher
  75. Weist B, Wehler P, El Ahmad L, Schmueck Henneresse M, Millward J, Nienen M, et al. A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients. Kidney Int. 2015;88:1293-1303 pubmed publisher
  76. O Carroll S, Kho D, Wiltshire R, Nelson V, Rotimi O, Johnson R, et al. Pro-inflammatory TNFα and IL-1β differentially regulate the inflammatory phenotype of brain microvascular endothelial cells. J Neuroinflammation. 2015;12:131 pubmed publisher
  77. Han J, Li E, Chen L, Zhang Y, Wei F, Liu J, et al. The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. Nature. 2015;524:243-6 pubmed publisher
  78. Melgaço J, Morgado L, Santiago M, Oliveira J, Lewis Ximenez L, Hasselmann B, et al. A single dose of inactivated hepatitis A vaccine promotes HAV-specific memory cellular response similar to that induced by a natural infection. Vaccine. 2015;33:3813-20 pubmed publisher
  79. Chowdhury A, Hayes T, Bosinger S, Lawson B, Vanderford T, Schmitz J, et al. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques. J Virol. 2015;89:8677-86 pubmed publisher
  80. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  81. Rochman Y, Yukawa M, Kartashov A, Barski A. Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig. PLoS ONE. 2015;10:e0122198 pubmed publisher
  82. Inglis H, Danesh A, Shah A, Lacroix J, Spinella P, Norris P. Techniques to improve detection and analysis of extracellular vesicles using flow cytometry. Cytometry A. 2015;87:1052-63 pubmed publisher
  83. Vassena L, Giuliani E, Koppensteiner H, Bolduan S, Schindler M, Doria M. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes. J Virol. 2015;89:5687-700 pubmed publisher
  84. Obiero J, Shekalaghe S, Hermsen C, Mpina M, Bijker E, Roestenberg M, et al. Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection. Infect Immun. 2015;83:2185-96 pubmed publisher
  85. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed publisher
  86. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  87. Konadu K, Chu J, Huang M, Amancha P, Armstrong W, Powell M, et al. Association of Cytokines With Exosomes in the Plasma of HIV-1-Seropositive Individuals. J Infect Dis. 2015;211:1712-6 pubmed publisher
  88. Crompton J, Sukumar M, Roychoudhuri R, Clever D, Gros A, Eil R, et al. Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res. 2015;75:296-305 pubmed publisher
  89. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed publisher
  90. van der Waart A, van de Weem N, Maas F, Kramer C, Kester M, Falkenburg J, et al. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood. 2014;124:3490-500 pubmed publisher
  91. Luetke Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 2014;10:e1004441 pubmed publisher
  92. Alnabhan R, Madrigal A, Saudemont A. Differential activation of cord blood and peripheral blood natural killer cells by cytokines. Cytotherapy. 2015;17:73-85 pubmed publisher
  93. Brandau S, Jakob M, Bruderek K, Bootz F, Giebel B, Radtke S, et al. Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes. PLoS ONE. 2014;9:e106903 pubmed publisher
  94. Toapanta F, Simon J, Barry E, Pasetti M, Levine M, Kotloff K, et al. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Front Immunol. 2014;5:374 pubmed publisher
  95. Antsiferova O, Müller A, Rämer P, Chijioke O, Chatterjee B, Raykova A, et al. Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice. PLoS Pathog. 2014;10:e1004333 pubmed publisher
  96. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  97. Weist B, Schmueck M, Fuehrer H, Sattler A, Reinke P, Babel N. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol. 2014;203:395-408 pubmed publisher
  98. Pegram H, Purdon T, van Leeuwen D, Curran K, Giralt S, Barker J, et al. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia. 2015;29:415-22 pubmed publisher
  99. Hu N, Mora Jensen H, Theilgaard Monch K, Doornbos van der Meer B, Huitema M, Stegeman C, et al. Differential expression of granulopoiesis related genes in neutrophil subsets distinguished by membrane expression of CD177. PLoS ONE. 2014;9:e99671 pubmed publisher
  100. Headland S, Jones H, D Sa A, Perretti M, Norling L. Cutting-edge analysis of extracellular microparticles using ImageStream(X) imaging flow cytometry. Sci Rep. 2014;4:5237 pubmed publisher
  101. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  102. Rossi E, Chang C, Goldenberg D. Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus. PLoS ONE. 2014;9:e98315 pubmed publisher
  103. Cartellieri M, Koristka S, Arndt C, Feldmann A, Stamova S, von Bonin M, et al. A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. PLoS ONE. 2014;9:e93745 pubmed publisher
  104. Riese S, Kuehne C, Tedder T, Hallmann R, Hohenester E, Buscher K. Heterotropic modulation of selectin affinity by allosteric antibodies affects leukocyte rolling. J Immunol. 2014;192:1862-9 pubmed publisher
  105. Teirlinck A, McCall M, Roestenberg M, Scholzen A, Woestenenk R, de Mast Q, et al. Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog. 2011;7:e1002389 pubmed publisher
  106. Markley J, Sadelain M. IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood. 2010;115:3508-19 pubmed publisher
  107. Cernea S, Herold K. Monitoring of antigen-specific CD8 T cells in patients with type 1 diabetes treated with antiCD3 monoclonal antibodies. Clin Immunol. 2010;134:121-9 pubmed publisher
  108. Prakobphol A, Genbacev O, Gormley M, Kapidzic M, Fisher S. A role for the L-selectin adhesion system in mediating cytotrophoblast emigration from the placenta. Dev Biol. 2006;298:107-17 pubmed
  109. Zdravkovic T, Genbacev O, Prakobphol A, Cvetkovic M, Schanz A, McMaster M, et al. Nicotine downregulates the l-selectin system that mediates cytotrophoblast emigration from cell columns and attachment to the uterine wall. Reprod Toxicol. 2006;22:69-76 pubmed
  110. Bratke K, Kuepper M, Bade B, Virchow J, Luttmann W. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood. Eur J Immunol. 2005;35:2608-16 pubmed
  111. Kemp T, Ludwig A, Earel J, Moore J, Vanoosten R, Moses B, et al. Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L. Blood. 2005;106:3474-82 pubmed
  112. Crough T, Burrows J, Fazou C, Walker S, Davenport M, Khanna R. Contemporaneous fluctuations in T cell responses to persistent herpes virus infections. Eur J Immunol. 2005;35:139-49 pubmed
  113. Biancone L, Cantaluppi V, Duò D, Deregibus M, Torre C, Camussi G. Role of L-selectin in the vascular homing of peripheral blood-derived endothelial progenitor cells. J Immunol. 2004;173:5268-74 pubmed
  114. Tan P, Chan C, Xue S, Dong R, Ananthesayanan B, Manunta M, et al. Phenotypic and functional differences between human saphenous vein (HSVEC) and umbilical vein (HUVEC) endothelial cells. Atherosclerosis. 2004;173:171-83 pubmed
  115. Lester E, Babensee J. Proinflammatory phenotype of endothelial cells after coculture with biomaterial-treated blood cells. J Biomed Mater Res A. 2003;64:397-410 pubmed
  116. Braun R, Foerster M, Grahmann P, Haefner D, Workalemahu G, Kroegel C. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases. Cytometry B Clin Cytom. 2003;54:19-27 pubmed
  117. Greco N, Lee W, Kurtz J, Seetharaman S, Moroff G. Characterization of multiple CD34+ cell populations in cord blood. J Hematother Stem Cell Res. 2003;12:199-213 pubmed
  118. Ku C, Padilla J, Grose C, Butcher E, Arvin A. Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers. J Virol. 2002;76:11425-33 pubmed
  119. Rutella S, Pierelli L, Bonanno G, Sica S, Ameglio F, Capoluongo E, et al. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood. 2002;100:2562-71 pubmed
  120. Sharron M, Pohlmann S, Price K, Lolis E, Tsang M, Kirchhoff F, et al. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. Blood. 2000;96:41-9 pubmed
  121. Greenberg A, Kerr W, Hammer D. Relationship between selectin-mediated rolling of hematopoietic stem and progenitor cells and progression in hematopoietic development. Blood. 2000;95:478-86 pubmed
  122. Lee B, Sharron M, Montaner L, Weissman D, Doms R. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-20 pubmed